Clinical trial
A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of…
NCT00140426 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00140426 |
|---|---|
| Title | A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa |
| Official title | A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | Janssen Pharmaceuticals Industry National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anorexia Nervosa |
| Intervention type | Drug |
| Interventions | Risperidone, Placebo |
| Enrollment | 41 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 1, 2005 |
| Last update posted | Feb 2, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: